We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Diabetic Kidney Disease and Risk of Incident Stroke Among T2D Adults

By LabMedica International staff writers
Posted on 08 Apr 2022
Print article
Image: The BN II System is an easy-to-use, reliable nephelometric analyzer that offers a broad range of protein assays (Photo courtesy of Siemens Healthineers)
Image: The BN II System is an easy-to-use, reliable nephelometric analyzer that offers a broad range of protein assays (Photo courtesy of Siemens Healthineers)

Atherosclerotic cardiovascular disease (ASCVD) is a significant cause of morbidity and mortality among people with type 2 diabetes (T2D) . The huge burden of ASCVD in T2D, mainly coronary artery disease (CAD) and stroke, constitutes a major public health problem in this population and accounts for significant disability and healthcare costs.

Diabetes mellitus is associated with a 3-fold greater age-adjusted risk of stroke and a higher post-stroke mortality. The increased burden of stroke in individuals with T2D is driven in large part by the high prevalence of the metabolic syndrome components in this population. However, accruing evidence suggest that other factors such as diabetes-related microvascular complications might play a role. Indeed, diabetic retinopathy was found to be associated with higher risk of stroke in people with T2D.

A team of medical scientists collaborating with those at SOVAH Health (Danville, VA, USA) included in their study a total of 9,170 participants; mean age: 62.8 ± 6.6 years, 38.2% women, 62.9% white. Of the entire sample, 62.2% of participants had no chronic kidney disease (CKD); 13.3%, CKD G1; 14.1%, CKD G2; and 10.5%, CKD G3. Urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) were assessed at baseline.

Urine microalbumin was assayed on spot urine by immunonephelometry on a BN11 nephelometer (Siemens Healthineers, Erlangen, Germany). Urinary albumin excretion was estimated as the urine albumin-to-creatinine ratio (UACR) in mg albumin/g of creatinine. eGFR was calculated in mL/min/1.73 m2 using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. Serum and urine creatinine was measured via enzymatic methods on a Roche Double Modular P Analytics automated analyzer (Roche Diagnostics, Indianapolis, IN , USA).

The scientists reported that over a median follow-up of 4.9 years, 156 participants developed a stroke (incidence rate 3.6/1,000 person-years). After adjusting for relevant confounders, higher UACR and lower eGFR were each associated with increased risk of stroke. Compared to UACR < 30 mg/g, moderate albuminuria and severe albuminuria were associated with increasing hazards for stroke (HR 1.61 and 2.29 respectively). Compared to eGFR of ≥ 60 mL/min/1.73 m2, decreased eGFR (eGFR < 60 mL/min/1.73 m2) was associated with higher risk of stroke (HR 1.50). Compared to no CKD, worsening CKD stage was associated with an increasing risk of stroke (HRs of 1.76 for CKD G1, 1.77 for CKD G2, and 2.03 for CKD G3).

The authors concluded that in a large and diverse cohort of adults with type 2 diabetes, higher UACR, decreased eGFR, and worsening CKD stages were associated with increased risk of stroke, independently of other stroke risk factors. The study was published on March 29, 2022 in the journal BMC Medicine.

Related Links:
SOVAH Health
Siemens Healthineers 
Roche Diagnostics 

Gold Supplier
RIELE Photometer 505
Automatic Photometer
Gold Supplier
Automatic Biochemistry Analyzer
Biossays C8
Washer Dispenser

Print article


Molecular Diagnostics

view channel
Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons)

Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis

A recent study added weight to the theory that methylated DNA biomarkers could be used for cancer diagnosis and prognosis. Methylation is a biological process by which methyl groups are added to a DNA molecule.... Read more


view channel
Image: Standard test for multiple myeloma provides clues of a rare, more deadly type (Photo courtesy of Pexels)

Standard Blood Cancer Test Provides Clues of Rare IgD Multiple Myeloma

IgD myeloma accounts for about 1% of common blood cancer multiple myeloma and has a worse prognosis. Specific testing for IgD myeloma is available at a handful of reference labs across the US, but takes... Read more


view channel
Image: QIAGEN has acquired a majority stake in enzymes provider BLIRT S.A. (Photo courtesy of QIAGEN)

Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business

QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.